Inflammatory and structural evaluation in spondylarthritis: Magnetic resonance imaging analysis of axial and peripheral involvement

Journal of Rheumatology

Volumn 34, Issue 4, 2007, Pages 762-768

  Hoenen Clavert, Virginie ^a   Rat, Anne Christine ^a   Loeuille, Damien ^b   Bettembourg Brault, Isabelle ^a   Michel Batot, Christine ^a   Blum, Alaln ^b   Pourel, Jacques ^b   Chary Valckenaere, Isabelle ^b,c  

^a CHU NANCY BRABOIS   (France)

^b Biopôle de l Université de Lorraine   (France)

^c Unite Mixte de Rech 7561 CNRS Universite Nancy 1 Physiopathologie et Pharmacologie Articulaires ^*  (France)

Author keywords

Inflammatory criteria; Magnetic resonance imaging; Spondyloarthropathy; Structural criteria

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA BLOCKING AGENT; UNCLASSIFIED DRUG;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL ARTICLE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; IMAGE ANALYSIS; INFLAMMATION; LIGAMENT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; TENOSYNOVITIS;

FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; JOINTS; LIGAMENTS; MAGNETIC RESONANCE IMAGING; MALE; OBSERVER VARIATION; OSTEITIS; PAIN MEASUREMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; SPONDYLARTHROPATHIES; SYNOVITIS; TENOSYNOVITIS;

EID: 34247398784     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Braun J, Bollow M, Remlinger G, et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998;41:58-67.
2. Gran JT, Husby G, Hordvik M. Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromso, northern Norway. Ann Rheum Dis 1985;44:359-67.
3. Wright V, Roberts MC, Hill AG. Dermatological manifestations in psoriatic arthritis: a follow-up study. Acta Derm Venereol 1979;59:235-40.
4. Saraux A, Guillemin F, Guggenbuhl P, et al. Prevalence of spondyloarthropathy in France. Ann Rheum Dis 2005;64:1431-5.
5. McGonagle D, Marzo-Ortega H, Benjamin M, Emery P. Report on the Second International Enthesitis Workshop. Arthritis Rheum 2003;48:896-905.
6. D'Agostino MA, Said-Nahal R, Hacquard-Bouder C, Brasseur JL, Dougados M, Breban M. Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional study. Arthritis Rheum 2003;48:523-33.
7. Balint PV, Kane D, Wilson H, McInnes IB, Sturrock RD. Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis 2002;61:905-10.
8. Milosavljevic J, Lindqvist U, Elvin A. Ultrasound and power Doppler evaluation of the hand and wrist in patients with psoriatic arthritis. Acta Radiol 2005;46:374-85.
9. Braun J, Baraliakos X, Golder W, et al. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum 2003;48:1126-36.
10. Rudwaleit M, Baraliakos X, Listing J, Brandt J, Sieper J, Braun J. Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept. Ann Rheum Dis 2005;64:1305-10.
11. Maksymowych WP, Inman RD, Salonen D, et al. Spondyloarthritis Research Consortium of Canada magnetic resonance imaging index for assessment of spinal inflammation in ankylosing spondylitis. Arthritis Rheum 2005;53:502-9.
12. Marzo-Ortega H, McGonagle D, Jarret S, et al. Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study. Ann Rheum Dis 2005;64:1568-75.
13. Maksymowych WP, Lambert R, Jhangri GS, et al. Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy. J Rheumatol 2001;28:144-55.
14. Cimmino MA, Parodi M, Innocenti S, et al. Dynamic magnetic resonance of the wrist in psoriatic arthritis reveals imaging patterns similar to those of rheumatoid arthritis. Arthritis Res Ther 2005;7:725-31.
15. Lambert RG, Dhillon SS, Jhangri GS, et al. High prevalence of symptomatic enthesopathy of the shoulder in ankylosing spondylitis: deltoid origin involvement constitutes a hallmark of disease. Arthritis Rheum 2004;51:681-90.
16. Erdem CZ, Sarikaya S, Erdem LO, Ozdolap S, Gundogdu S. MR imaging features of foot involvement in ankylosing spondylitis. Eur J Radiol 2005;53:110-9.
17. Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
18. Braun J, Pham T, Sieper J, et al. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 2003;62:817-24.
19. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
20. Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
21. Bigot JL, Loeuille D, Chary-Valckenaere I, Pourel J, Cao MM, Blum A. Determination of the best MRI criteria for diagnosis of sacroiliitis. J Radiol 1999;80:1649-57.
22. Ostergaard M, Gideon P, Sorensen K, et al. Scoring of synovial membrane hypertrophy and bone erosions by MR imaging in clinically active and inactive rheumatoid arthritis of the wrist. Scand J Rheumatol 1995;24:212-8.
23. Lassere M, McQueen F, Ostergaard M, et al. OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Exercise 3: an international multicenter reliability study using the RA-MRI Score. J Rheumatol 2003;30:1366-75.
24. Marzo-Ortega H, McGonagle D, O'Connor P, Emery P. Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study. Arthritis Rheum 2001;44:2112-7.
25. Maksymowych WP, Jhangri GS, Lambert RG, et al. Infliximab in ankylosing spondylitis: a prospective observational inception cohort analysis of efficacy and safety. J Rheumatol 2002;29:959-65.
26. Antoni C, Dechant C, Hanns-Martin Lorenz PD, et al. Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation. Arthritis Rheum 2002;47:506-12.
27. Ostergaard M, Stoltenberg M, Lovgreen-Nielsen P, Volck B, Sonne-Holm S, Lorenzen I. Quantification of synovitis by MRI: correlation between dynamic and static gadolinium-enhanced magnetic resonance imaging and microscopic and macroscopic signs of synovial inflammation. Magn Reson Imaging 1998;16:743-54.
28. Cimmino MA, Innocenti S, Livrone F, Magnaguagno F, Silvestri E, Garlaschi G. Dynamic gadolinium-enhanced magnetic resonance imaging of the wrist in patients with rheumatoid arthritis can discriminate active from inactive disease. Arthritis Rheum 2003;48:1207-13.
29. McQueen FM, Crabbe J, Stewart N. Dynamic gadolinium-enhanced magnetic resonance imaging of the wrist in patients with rheumatoid arthritis: comment on the article by Cimmino et al. Arthritis Rheum 2004;50:674-5.
30. Baeten D, Demetter P, Cuvelier C, et al. Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity. Ann Rheum Dis 2000;59:945-53.
31. Vlam K, Mielants H, Veys EM. Involvement of zygapopyseal joint in ankylosing spondylitis: relation to the bridging syndesmophyte. J Rheumatol 1999;26:1738-45.
32. Braun J, Bollow M, Sieper J. Radiologic diagnosis and pathology of the spondylarthropathies. Rheum Dis Clin North Am 1998;24:697-735.